Objective
Increasing patient knowledge about the value of colorectal cancer (CRC) screening is a goal of most public health education efforts. We hypothesized that a cohort of women at average risk for CRC, but non-compliant with standard screening recommendations, would demonstrate low levels of CRC related knowledge and underestimate their personal risk for developing CRC.
Methods
Baseline survey results are reported from a prospective trial designed to improve CRC screening participation in women at average risk, but non-complaint with screening recommendations. Women scheduled for a routine gynecological office visit were identified and contacted by telephone approximately 4 weeks before their index appointment. All participants completed a 75 item baseline survey that included items assessing demographic information, CRC knowledge, risk perception and intention to participate in screening.
Results
Women (n=318) enrolled from June, 2006-May, 2007 are included. Participants demonstrated high levels of CRC and CRC screening related knowledge answering an average of 8.6/10 items correctly (SD 1.30). The majority of these non-compliant women (1) estimated their CRC risk incorrectly (60%) and (2) had no intention of CRC screening participation in the future (65%). Multivariate models found no consistent relationships between knowledge, risk perception, and screening intent.
Conclusions
Greater “knowledge” alone is an inadequate stimulus to CRC screening adherence. Future interventions will require a greater understanding of the interplay between CRC-related knowledge, beliefs, risk perception, and other affective responses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.